Nicolas Mouawad, MD, Chief and Medical Director, Vascular and Endovascular Surgery, McLaren Bay Region A Tale of two lesions.

Slides:



Advertisements
Similar presentations
Multivessel PCI procedure complicated with fracture of the wire Marcin D ę binski, MD Head: Pawel E. Buszman, MD, FACC University Hospital of Silesia,
Advertisements

Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
Subtitle Text Here Zylon Medical Devices Smaller Is Better Supported by NIH SBIR PHASE II Grant # 5 R44 H
DEFINITIVE AR - Acute Outcomes -
AVE Micro Stent KFSH & RC Experience with 6 months Angiographic Follow Up Layth A. Mimish, M. Bakhshi, F. Al-Nozha, A. Kinsara, O. Amoudi, J. Buraiki,
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
Evaluation of ReeKross balloon catheter in treating iliofemoral artery chronic total occlusions Xinwu Lu Vascular Center of Shanghai Jiaotong University.
Klinikum Rosenheim Department of Diagnostic and Interventional Radiology LINC 2014 DEFINITIVE AR Severe Ca++ Arm 30-Day Results Gunnar Tepe, MD On behalf.
Aims To evaluate the technical and clinical outcome of percutaneous transluminal infra-popliteal angioplasties (PTIA) +/- stenting in a subgroup of patients.
Achieving Acute Success and Durable Results with Complete Total Occlusion? Christopher J. Kwolek, MD FACS Harvard Medical School Division of Vascular and.
Importance Of Proximal Angle And Interpolated Minimal Luminal Diameter In Coronary Bifurcation Lesions Bhaktha M.D. Maddhavapeddy Aditya M.D. Maddury Jyotsna.
Endovascular Treatment of Atherosclerotic Popliteal Artery Lesions – Balloon Angioplasty versus primary Stenting: A prospective, multi-centre, randomised.
UpdateDEB Lesions Learned from the Trials and Daily Clinical Practice Ralf Langhoff, MD Center for Vascular Medicine Berlin-Wilmersdorf St. Gertrauden.
FMRP 2014 | 1 Marc Bosiers Koen Deloose Joren Callaert A.Z. Sint-Blasius, Dendermonde Imelda Hospital, Bonheiden Patrick Peeters Jürgen Verbist OLV Hospital,
Material and Methods Patient Population. – From July 2005 through December 2008, 130 patients (130 procedures, 154 limbs, 185 lesions) were treated using.
Interventional Treatment of obstructive aortoiliac disease Dr Afshin Ghofraniha Interventional Cardiologist.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
November 9, 2015 February 20, 2017 Using real world evidence – industry perspective Pma indication expansion Melissa hasenbank, phd Sr. Clinical Research.
Antegrade Femoral Artery Access
Open cervical approach for carotid artery stenting
Global Experience with Peripheral DCBs/Stent Studies: C.R. Bard
The Endocross Enabler-P: First in-Human Results
Disrupt CAD Study Design
Can Drug-Coated Balloons Work in Synergy with Stent Grafts?
G. Capretti, M. Carlino, A. Colombo, L. Azzalini
Takashi Ashikaga,MD,PhD
Transradial Intervention: Complex Case Review Yes, They Can Be Done!
Lutonix® Paclitaxel-Coated Balloon to Treat Obstructive Lesions in the Superficial Femoral and Popliteal Arteries Preliminary Six-Month Results from.
Interesting Case Presentation
Direct access of the SFA: step by step
Heavily calcified SFA lesions do not avoid the use of 4 F systems
Fem-Pop Stenting: Is ZILVER PTX DES The “De Facto” Stent to Deploy?
James P. Zidar, M.D., F.A.C.C., F.S.C.A.I
Michael Siah, M.D. Medstar Georgetown University Hospital
A strange post-CABG presentation
Treating Infrapopliteal Disease Using a Primarily Retrograde Technique
Stent Graft for the Treatment of ISR:
Clinical Presentation
(DES)+BVS +DCB for long diffuse LAD disease
Angiographic Features of Atherosclerotic Superficial Femoral Artery Disease in Diabetics and Non-diabetics Presenting with Claudication Atif Mohammad,
The Radial Approach for CTO PCI Utility in the Retrograde and the Antegrade Approaches Shigeru Saito, MD, FACC, FSCAI, FJCC Shonan Kamakura General Hospital.
University-Heart Center Freiburg - Bad Krozingen
History : Case June 18’ year old male patient with complaints of life style limiting claudication symptoms in right leg at rest (Rutherford Grade.
Meruzhan Saghatelyan, MD, Interventional cardiologist
Crossing SFA-Popliteal Artery CTO’s
How to do endovascular mechanical thrombaspiration
SFA Access for TASC D lesions.
History : Case March 26, year old male patient with complaints of left calf pain (Typical Claudication) at rest and on exertion (Fontaine II/B).
Excimer Laser Atherectomy for the Treatment of Infra-inguinal Peripheral Arterial Disease Bryan P Yan MD, Thomas J Kiernan MD, Vishal Gupta MD,
BVS Expand: First Results of Wide Clinical Applications
The XIENCE V EXCEED Study
Subintimal Tracking and Reentry for CTO STAR Method
Medical Director of the Vascular Center
Recanilization of Central Venous Total Occlusions
William A. Gray MD Director of Endovascular Services
Essesntials for CTO Recanalization
James P. Zidar, M.D., F.A.C.C., F.S.C.A.I
Crystal M. Kavanagh, MD, Michael J. Heidenreich, MD, Jeremy J
Biomedical Engineering for Global Health
Early infection risk with primary versus staged Hemodialysis Reliable Outflow (HeRO) graft implantation  Andrew S. Griffin, MD, Shawn M. Gage, PA-C, Jeffrey.
Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices 
Division of Endovascular Interventions Mount Sinai Hospital, NY
12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting.
Limitations of the Outback LTD re-entry device in femoropopliteal chronic total occlusions  Susanna H. Shin, MD, Donald Baril, MD, Rabih Chaer, MD, Robert.
Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization 
Endovascular Live Case Mount Sinai Hospital, NY
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
Atlantic Cardiovascular Patient Outcomes Research Team
A new approach to carotid angioplasty and stenting with transcervical occlusion and protective shunting: why it may be a better carotid artery intervention 
Karthikeshwar Kasirajan, MD, Peter A Schneider, MD 
Presentation transcript:

Nicolas Mouawad, MD, Chief and Medical Director, Vascular and Endovascular Surgery, McLaren Bay Region A Tale of two lesions

Patient Background 67 year old Male Hypertension History of smoking Rest pain Rutherford Class 3 TASC II: C No previous interventions Pre-Procedure ABI: 0.18

Diagnostic

Diagnostic

Treatment to the Left SFA/POP 2 Lesions Moderate/Severe Calcification Lesion in the proximal SFA Treated with a DCB only CTO in the POP Vessel Diameter: 5 mm Lesion Length: 60 mm Lesion treated with the FLEX Dynamic Scoring Catheter and a DCB POBA was NOT used prior to DCB in either location.

Vessel Preparation FLEX Dynamic Scoring Catheter® One-Size-Fits-All Device / 1 SKU Inventory 6 Fr / .014 and .018 Guidewire Compatible 40 cm and 120 cm Working Length Engineered for continuous parallel micro-incisions by 3 Atherotomes FLEX predilates the stenosis, skids apply a constant pressure (1 atm) Controlled depth micro-incisions (Atherotome Height 0.01”) Rotationally controlled, provides the ability to create multiple scores

Early Clinical Results Utilizing the FLEX Scoring Catheter in 100 Femoropopliteal Chronic Total Occlusions. Presented at ISET January 2018 Thomas Zeller, MD, PhD, Universitaets-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen 24 operators in 15 hospital systems The FLEX is effective in recanalizing CTOs with low rates of vessel dissection. Results Average Lesion Length (mm) 191 Luminal Gain Post FLEX 31% DCB Use 70% Average Opening Balloon Pressure (atm) 4.1 Residual Stenosis Post FLEX + Angioplasty 7.9% Provisional Stent Use 19% Moderate / Severe Calcium 46%

Real World Results of a Dynamic Scoring Device in Calcified Femoropopliteal Vessels Presented at CVC 2018 Frank Arko, MD, Director Endovascular Surgery, Sanger Heart and Vascular Institute, North Carolina Results None – Mild Moderate - Severe Number of Lesions 140 177 Average Lesion Length (mm) 110.5 145.6 Luminal Gain Post FLEX 24% 30% DCB Use 78% 73% Average Opening Balloon Pressure (atm) 4.5 4.6 Residual Stenosis Post FLEX + Angioplasty 9% 11.6% Flow-Limiting Dissection 0% Emboli / Perforations 83 operator, 55 health systems Low balloon opening pressures FLEX is Safe and Effective in Calcium

3 passes with the FLEX Scoring Catheter 30° rotation between each pass FLEX achieved 60% luminal gain

Straight to DCB IN.PACT: 4x150 and 5x150 Balloon fully effaced at 4 atm Balloon inflated to nominal Inflation held for 3 minutes Residual Stenosis: 10% **No dissections, emboli, or perforations after FLEX + DCB

Final Result Proximal SFA Lesion Treated with IN.PACT only Non flow-limiting dissection occurred CTO in POP Treated with FLEX and IN.PACT No Dissections or Emboli

Final Result

Conclusion Without vessel prep, angioplasty resulted in a non-flow-limiting dissection. Vessel Prep with the FLEX: CTO was successfully recanalized Luminal gain achieved Improved vessel compliance Evident by the low balloon opening pressure No dissections No stents Vessel preparation with the FLEX helps to avoids stents and dissections. FLEX + DCB saves time and radiation exposure